Because the overexpression of HER2 in primary breast cancers is associated with periductal neovascularity and increased intratumoral microvessel density [26, 27], we suspect that Ktrans may be associated with the HER2 status of breast cancer brain metastases. Here, ERBB2 is linked to breast carcinoma.